Patents by Inventor Peter A. Altman
Peter A. Altman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10874831Abstract: A steerable guide sheath system adapted for delivery into a patient's vasculature. The pull wire which is used to tension the deflectable portion of the sheath is wrapped or twisted around the axis of the sheath.Type: GrantFiled: October 6, 2015Date of Patent: December 29, 2020Assignee: BIOCARDIA, INC.Inventors: Daniel C. Rosenman, Daniel Kayser, Peter A. Altman
-
Patent number: 10632281Abstract: A system and method for delivering a drug to a target site within a patient's body. The system and method include a steerable guide catheter and a drug delivery catheter. The steerable guide catheter has a first extension tube and a second extension tube that are joined together and form a shoulder. The delivery catheter has a distal docking segment and a proximal docking segment. The guide catheter is inserted into the patient's body, then the delivery catheter is inserted into the guide catheter. The distal docking segment engages the first extension tube, the proximal docking segment engages the second extension tube, and the shoulder limits the distance the delivery catheter can be inserted into the guide catheter. Also, once the delivery catheter is inserted it can be rotated to attach the helical tip to the target site. The guide catheter also includes a steering mechanism as well as a friction mechanism which controls the tension on the steering mechanism.Type: GrantFiled: April 21, 2014Date of Patent: April 28, 2020Assignee: BioCardia, Inc.Inventors: Daniel C. Rosenman, Peter A. Altman, Brian K. Hakim, Daniel J. Kayser, Robert E. Maston, Douglas McEtchin
-
Publication number: 20170266107Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).Type: ApplicationFiled: November 2, 2016Publication date: September 21, 2017Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
-
Patent number: 9517199Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).Type: GrantFiled: February 24, 2015Date of Patent: December 13, 2016Assignee: BioCardia, Inc.Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
-
Patent number: 9504642Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).Type: GrantFiled: July 30, 2013Date of Patent: November 29, 2016Assignee: BioCardia, Inc.Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
-
Patent number: 9301975Abstract: A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium which can be used in a clinical setting, and a business method for performing such expansions in the future as a service for patients. A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium including a diagnostic kit for the autologous cell therapy to determine whether a patient will respond to the autologous cell therapy for treatment of a disease, in which said kit comprising a system for detecting gene and protein expression comprising at least two isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene that is differentially expressed in the tissue of the patient that is intended to be the source of the autologous cell therapy.Type: GrantFiled: May 1, 2009Date of Patent: April 5, 2016Assignee: Biocardia, Inc.Inventors: Didier Rouy, Peter A. Altman, Benjamin Koziner
-
Publication number: 20160022961Abstract: A steerable guide sheath system adapted for delivery into a patient's vasculature. The pull wire which is used to tension the deflectable portion of the sheath is wrapped or twisted around the axis of the sheath.Type: ApplicationFiled: October 6, 2015Publication date: January 28, 2016Applicant: BIOCARDIA, INC.Inventors: Daniel C. Rosenman, Daniel Kayser, Peter A. Altman
-
Publication number: 20150314106Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: ApplicationFiled: July 13, 2015Publication date: November 5, 2015Applicant: Biocardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Patent number: 9078994Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: GrantFiled: August 13, 2013Date of Patent: July 14, 2015Assignee: BioCardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Publication number: 20150164786Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).Type: ApplicationFiled: February 24, 2015Publication date: June 18, 2015Applicant: BioCardia, Inc.Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
-
Patent number: 9022977Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: GrantFiled: June 11, 2013Date of Patent: May 5, 2015Assignee: BioCardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Patent number: 9017284Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: GrantFiled: August 13, 2013Date of Patent: April 28, 2015Assignee: BioCardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Patent number: 9011373Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: GrantFiled: August 13, 2013Date of Patent: April 21, 2015Assignee: BioCardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Publication number: 20150041532Abstract: A system and method for tracking longitudinal data for the maintenance and management of health of an individual. The method entails marking numerous groceries, drugs, beverages, etc., with labels that may be read by a scanner or reader embedded in a PDA or cell phone or similar small electronic device, and providing users with a suitable scanner or reader. Users scan the labels of the products they consume during the course of a day, and the system keeps track of calories, fat content, carbohydrate content, etc. of the food consumed, drug content of the drugs consumed, etc. The system can also be operated to track exercise levels and energy expenditure during the day. The system is operable to provide a comparative display of various databased information, such as calorie intake versus calorie expenditure during exercise.Type: ApplicationFiled: October 22, 2014Publication date: February 12, 2015Inventor: Peter A. Altman
-
Patent number: 8939960Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: GrantFiled: July 22, 2008Date of Patent: January 27, 2015Assignee: BioCardia, Inc.Inventors: Daniel Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Publication number: 20140228748Abstract: A system and method for delivering a drug to a target site within a patient's body. The system and method include a steerable guide catheter and a drug delivery catheter. The steerable guide catheter has a first extension tube and a second extension tube that are joined together and form a shoulder. The delivery catheter has a distal docking segment and a proximal docking segment. The guide catheter is inserted into the patient's body, then the delivery catheter is inserted into the guide catheter. The distal docking segment engages the first extension tube, the proximal docking segment engages the second extension tube, and the shoulder limits the distance the delivery catheter can be inserted into the guide catheter. Also, once the delivery catheter is inserted it can be rotated to attach the helical tip to the target site. The guide catheter also includes a steering mechanism as well as a friction mechanism which controls the tension on the steering mechanism.Type: ApplicationFiled: April 21, 2014Publication date: August 14, 2014Applicant: BioCardia, Inc.Inventors: Daniel C. Rosenman, Peter A. Altman, Brian K. Hakim, Daniel J. Kayser, Robert E. Maston, Douglas McEtchin
-
Publication number: 20140012189Abstract: Catheter systems and methods for implanting helical or dart-like implants into the myocardium or other body tissue. The catheter system includes a helix for fixing the distal end of the catheter to the myocardium, an implant held by the helix, mechanisms for driving the fixation helix into the myocardium, and mechanisms for driving the implant into the myocardium, removing the fixation helix and leaving the implant behind. The implant may be coated, filled, or made of a drug or drug eluting compound, or drug delivery matrix of any composition.Type: ApplicationFiled: September 10, 2013Publication date: January 9, 2014Applicant: BioCardia, Inc.Inventors: Daniel C. Rosenman, Peter A. Altman, Mark A. Lovich, Michael A. Schwartz, Aaron J. Miller
-
Publication number: 20130331932Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: ApplicationFiled: August 13, 2013Publication date: December 12, 2013Applicant: BioCardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Publication number: 20130331819Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: ApplicationFiled: August 13, 2013Publication date: December 12, 2013Applicant: BioCardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
-
Publication number: 20130331881Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (1/3 mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.Type: ApplicationFiled: August 13, 2013Publication date: December 12, 2013Applicant: BioCardia, Inc.Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman